Scarica l'app Stockscreener
0.505
5.45%
0.0261
Dopo l'orario di chiusura:
.51
0.005
+0.99%
Precedente Chiudi:
$0.4789
Aprire:
$0.4835
Volume 24 ore:
114.63K
Relative Volume:
0.19
Capitalizzazione di mercato:
$2.05M
Reddito:
$1.93M
Utile/perdita netta:
$-3.10M
Rapporto P/E:
-0.0208
EPS:
-24.3081
Flusso di cassa netto:
$-1.93M
1 W Prestazione:
-17.67%
1M Prestazione:
-29.76%
6M Prestazione:
-47.42%
1 anno Prestazione:
-78.14%
Intervallo 1D:
$0.4511
$0.51
Intervallo di 1 settimana:
$0.45
$0.6199
Portata 52W:
$0.45
$6.39
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
China Sxt Pharmaceuticals Inc Borsa (SXTC) Ultime notizie
SXTC stock touches 52-week low at $0.52 amid market challenges By Investing.com - Investing.com South Africa
SXTC stock touches 52-week low at $0.52 amid market challenges - Investing.com UK
In the Green: China SXT Pharmaceuticals Inc (SXTC) Closes at 0.63, Up/Down 12.64 from Previous Day - The Dwinnex
SXTC’s Stock Market Adventure: -84.07% YTD Growth Amidst Volatility - The InvestChronicle
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
Visteon to Announce Third Quarter 2024 Results - The Manila Times
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency - The Manila Times
China SXT Pharmaceuticals Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
SXTC’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Insider’s View: Deciphering China SXT Pharmaceuticals Inc (SXTC)’s Financial Health Through Ratios - The Dwinnex
SXTC’s Market Whiplash: -83.70% YTD Decline, -22.51% Plunge in 30 Days - The InvestChronicle
How does SXTC’s price to cash per share ratio compare in the market? - US Post News
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Decline in Short Interest - Defense World
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Large Increase in Short Interest - Defense World
China SXT Pharmaceuticals (NASDAQ:SXTC) Stock Quotes, Forecast and News Summary - Benzinga
China's First Generic Version of AstraZeneca's Xigduo XR Diabetes Pill Gets Green Light - Yicai Global
SIMPLY SOLVENTLESS PROVIDES Q3 2024 GUIDANCE INCLUDING RECORD PROJECTED QUARTERLY REVENUE AND EIGHTH STRAIGHT QUARTER OF NET INCOME PROFIT, AND ANNOUNCES UPCOMING PRODUCT LAUNCHES – Company A - Financial Times
China SXT Pharmaceuticals Inc (SXTC)’s results reveal risk - US Post News
China SXT Pharmaceuticals Inc (SXTC) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
SXTC stock touches 52-week low at $0.6 amid sharp annual decline - Investing.com India
Closing Figures Unveiled: China SXT Pharmaceuticals Inc (SXTC) Drop -8.88, Closes at 0.63 - The Dwinnex
SXTC stock plunges to 52-week low of $0.75 amid market challenges - Investing.com Australia
SXTC’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Market Resilience: China SXT Pharmaceuticals Inc (SXTC) Finishes Weak at 0.94, Down -6.00 - The Dwinnex
China SXT Pharma stock hits 52-week low at $0.92 amid downturn - Investing.com India
SXTC stock hits 52-week low at $0.93 amid sharp annual decline - Investing.com India
Navigating SXTC Stock: China SXT Pharmaceuticals Inc Journey - The InvestChronicle
Did China SXT Pharmaceuticals Inc (SXTC) perform well in the last session? - US Post News
China SXT Pharmaceuticals Inc (SXTC) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Balance Sheet Insights: China SXT Pharmaceuticals Inc (SXTC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
China SXT Pharmaceuticals Inc (SXTC) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Down 25.1% in June - Defense World
China SXT Pharmaceuticals Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - The InvestChronicle
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Market Watch Highlights: China SXT Pharmaceuticals Inc (SXTC) Ends on an Downturn Note at 1.06 - The Dwinnex
Examining China SXT Pharmaceuticals Inc (SXTC) stock is warranted - US Post News
China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment - Quantisnow
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Update - Defense World
Successful Portfolios LLC Lowers Stock Holdings in The Southern Company (NYSE:SO) - Defense World
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split - Quantisnow
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares ... - Quantisnow
China SXT Pharmaceuticals Inc Inc. (SXTC) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
A closer look at China SXT Pharmaceuticals Inc (SXTC) is warranted – US Post News - US Post News
Deeper Dive: Understanding China SXT Pharmaceuticals Inc (SXTC) Through its Various Ratios – DWinneX - The Dwinnex
SXTC’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
China SXT Pharmaceuticals Inc (SXTC) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Daily Market Movement: China SXT Pharmaceuticals Inc (SXTC) Sees a 0.94 Increase, Closing at 1.07 – DWinneX - The Dwinnex
Quarterly Metrics: Quick and Current Ratios for China SXT Pharmaceuticals Inc (SXTC) – DWinneX - The Dwinnex
China SXT Pharmaceuticals Inc (SXTC) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
China Sxt Pharmaceuticals Inc Azioni (SXTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.88%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):